Table 3.
Success rate (n, %), mean dose of propofol, recovery time (mean, standard deviation, range), patient tolerance and satisfaction, and endoscopist satisfaction (n, %)
| Group Ca (n = 52) | Group Nb (n = 48) | P value | |
|---|---|---|---|
| Success rate | 52 (100.0) | 48 (100.0) | 1.000 |
| Mean dose of propofol | |||
| Total dose (mg) | 198.7 (95.0), 30.0–490.0 | 247.3 (129.3), 60.0–590.0 | 0.037* |
| Dose/body weight (mg/kg) | 3.7 (1.8), 0.7–9.8 | 4.5 (2.1), 1.2–9.9 | 0.497 |
| Dose/body weight/time (mg/kg/h) | 6.8 (3.8), 1.7–18.0 | 7.7 (3.0), 2.8–16.8 | 0.136 |
| Recovery time (min) | 33.2 (15.7), 10.0–90.0 | 35.9 (15.8), 10.0–70.0 | 0.241 |
| Patient tolerance | 0.951 | ||
| Exceptional | 25 (48.1) | 22 (45.8) | |
| Well | 17 (32.7) | 18 (37.5) | |
| Fair | 8 (15.4) | 6 (12.5) | |
| Poor | 2 (3.8) | 2 (4.2) | |
| Patient satisfaction | 0.993 | ||
| Very satisfied | 27 (51.9) | 25 (52.1) | |
| Satisfied | 17 (32.7) | 16 (33.3) | |
| Neutral | 8 (15.4) | 7 (14.6) | |
| Dissatisfied | 0 | 0 | |
| Endoscopist satisfaction | 0.871 | ||
| Very satisfied | 20 (38.5) | 20 (41.7) | |
| Satisfied | 17 (32.7) | 17 (35.4) | |
| Neutral | 11 (21.1) | 9 (18.7) | |
| Dissatisfied | 4 (7.7) | 2 (4.2) |
Notes:
a
Group C: clinical assessment;
b
Group N: NarcotrendTM monitoring;
*
Considered to be of statistical significance.